Pfizer

You're Invited: Penbraya National Broadcast Event

We are very excited to invite you to join our virtual national broadcast program presented by Ruth M. Carrico, PhD, DNP, APRN, FNP-C, CIC, FSHEA, FNAP, FAAN and Jaime E. Fergie, MD, FAAP, FIDSA, FSHEA.

Below you will find an invitation for the program which includes event dates and times, featured speakers, and the link to register. Once registered, you’ll receive a confirmation email and reminder emails leading up to the program. Prior to the program, you’ll also receive an email containing a link to access the event and watch virtually.

Pfizer's Reminder Recall Resources are Available

There may be gaps in immunization coverage for your patients that leave them at risk for certain vaccine-preventable diseases.  The ACIP, AAP, and AAFP recommend the use of reminder recall systems by vaccination providers to increase vaccination rates.  

Pfizer offers reminder recall resources that may help support your organization's efforts to increase vaccination and well visit adherence through personalized postcards that can assist in your vaccination outreach efforts.  These postcards are not brand-specific and are intended for your patients who may have missed or are due for CDC-recommended vaccines, or who may be due for a well visit.

 To learn more, click here and share your contact information via email to request a call from a Pfizer Vaccines representative to review Pfizer's reminder recall resources and the program enrollment process.  As a note, by providing your contact information, you are therefore affirming your consent to provide your contact information to a local Pfizer Vaccine Representative.  

Available July 1: the first over-the-counter test that offers fast and accurate testing for both COVID-19 and Flu A/B

Beginning July 1, 2024, the LUCIRA by Pfizer COVID-19 & Flu Test will be available to order for all PRN members. This cordless device gives you results in 30 minutes, showing a positive result in as few as 11 minutes.

LUCIRA by Pfizer COVID-19 and Flu A & B test offers the convenience of an in-office test with molecular testing and PCR-quality accuracy for ages 2 and up.

Swab, stir and detect. 3 simple steps with an easy-to-read display. Click on the image below for more details.

Available April 1: The only FDA-approved vaccine that helps prevent all 5 leading types of meningococcal meningitis

Source: www.penbraya.com

PENBRAYA is available for order beginning April 1, 2024.  PENBRAYA is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y.  PENBRAYA is approved for use in individuals 10 through 25 years of age. 

PENBRAYA combines 2 vaccines that have nearly 10 years of experience to help protect against all 5 leading types of meningitis—A, B, C, W, and Y. Patients can now get the broadest protection against all 5 leading types of meningococcal meningitis with the fewest shots.

Click here for more information.

If you are interested in ordering, please contact Tina Clark, Contract Administrator, at tina@prn-gpo.com or (888)776-2360.